Novel Collective Effects in Integrated Photonics

Superradiance, the enhanced collective emission of energy from a coherent ensemble of quantum systems, has been typically studied in atomic ensembles. In this work we study theoretically the enhanced emission of energy from coherent ensembles of harmonic oscillators. We show that it should be possible to observe harmonic oscillator superradiance for the first time in waveguide arrays in integrated photonics. Furthermore, we describe how pairwise correlations within the ensemble can be measured with this architecture. These pairwise correlations are an integral part of the phenomenon of superradiance and have never been observed in experiments to date.Comment: 7 pages, 3 figure

Loop effects and non-decoupling property of SUSY QCD in gb→tH−g b\to tH^{-}

One-loop SUSY QCD radiative correction to $gb \to tH^{-}$ cross section is calculated in the Minimal Supersymmetric Standard Model. We found that SUSY QCD is non-decoupling if the gluino mass and the parameter $\mu$, $A_t$ or $A_b$ are at the same order and get large. The non-decoupling contribution can be enhanced by large $\tan\beta$ and therefore large corrections to the hadronic production rates at the Tevatron and LHC are expected in the large $\tan\beta$ limit. The fundamental reason for such non-decoupling behavior is found to be some couplings in the loops being proportional to SUSY mass parameters.Comment: 15 pages, 5 PS figures. A proof of non-decouplings of SUSY-QCD, Comments on corresponding QCD correction and references adde

Electric charge quantization and the muon anomalous magnetic moment

We investigate some proposals to solve the electric charge quantization puzzle, which simultaneously explain the recent measured deviation on the muon anomalous magnetic moment. For this we assess extensions of the Electro-Weak Standard Model spanning modifications on the scalar sector only. It is interesting to verify that one can have modest extensions which easily account for the solution for both problems.Comment: 20 pages, 1 figures, needs macro axodraw.st

Higgs-mediated leptonic decays of B_s and B_d mesons as probes of supersymmetry

If tan(beta) is large, down-type quark mass matrices and Yukawa couplings cannot be simultaneously diagonalized, and flavour violating couplings of the neutral Higgs bosons are induced at the 1-loop level. These couplings lead to Higgs-mediated contributions to the decays B_s -> mu+ mu- and B_d -> tau+ tau-, at a level that might be of interest for the current Tevatron run, or possibly, at B-factories. We evaluate the branching ratios for these decays within the framework of minimal gravity-, gauge- and anomaly-mediated SUSY breaking models, and also in SU(5) supergravity models with non-universal gaugino mass parameters at the GUT scale. We find that the contribution from gluino loops, which seems to have been left out in recent phenomenological analyses, is significant. We explore how the branching fraction varies in these models, emphasizing parameter regions consistent with other observations.Comment: Revised to accommodate minor changes in original text and update reference

Muon anomalous magnetic moment, B→XsγB\to X_s \gamma and dark matter detection in the string models with dilaton domination

We consider the muon anomalous magnetic moment $a_{\mu}$ in the string models with dilaton domination with two different string scales : the usual GUT scale and the intermediate scale. After imposing the direct search limits on the lightest neutral Higgs and SUSY particle masses and the lightest neutralino LSP, the $a_{\mu}^{\rm SUSY}$ is predicted to be less than $65 (55) \times 10^{-10}$ for $M_{string} = 2 \times 10^{16}$ GeV ($3 \times 10^{11}$ GeV). If we further impose the $B\to X_s \gamma$ branching ratio, the predicted $a_{\mu}^{\rm SUSY}$ becomes lower to $35 \times 10^{-10}$ for intermediate string scale. The resulting LSP - proton scattering cross section is less than $\sim 10^{-7}$ pb, which is below the sensitivity of the current direct dark matter search experiments, but could be covered by future experiments.Comment: PRD accepted versio

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362